178 related articles for article (PubMed ID: 32955822)
1. Challenges and new perspectives in the treatment of advanced cutaneous squamous cell carcinoma.
Brancaccio G; Moscarella E; Briatico G; Verolino P; Alfano R; Argenziano G
Minerva Med; 2020 Dec; 111(6):589-600. PubMed ID: 32955822
[TBL] [Abstract][Full Text] [Related]
2. Systemic Immunotherapy for Advanced Cutaneous Squamous Cell Carcinoma.
Ogata D; Tsuchida T
Curr Treat Options Oncol; 2019 Mar; 20(4):30. PubMed ID: 30874952
[TBL] [Abstract][Full Text] [Related]
3. Advanced cutaneous squamous cell carcinoma: how is it defined and what new therapeutic approaches are available?
Soura E; Gagari E; Stratigos A
Curr Opin Oncol; 2019 Sep; 31(5):461-468. PubMed ID: 31394558
[TBL] [Abstract][Full Text] [Related]
4. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
6. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
[TBL] [Abstract][Full Text] [Related]
7. Update of advanced cutaneous squamous cell carcinoma.
de Jong E; Lammerts MUPA; Genders RE; Bouwes Bavinck JN
J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1(Suppl 1):6-10. PubMed ID: 34855246
[TBL] [Abstract][Full Text] [Related]
8. Treatment approaches in immunosuppressed patients with advanced cutaneous squamous cell carcinoma.
Willenbrink TJ; Jambusaria-Pahlajani A; Arron S; Seckin D; Harwood CA; Proby CM
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():57-60. PubMed ID: 31833603
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma.
Claveau J; Archambault J; Ernst DS; Giacomantonio C; Limacher JJ; Murray C; Parent F; Zloty D
Curr Oncol; 2020 Aug; 27(4):e399-e407. PubMed ID: 32905333
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
Al-Rohil RN; Tarasen AJ; Carlson JA; Wang K; Johnson A; Yelensky R; Lipson D; Elvin JA; Vergilio JA; Ali SM; Suh J; Miller VA; Stephens PJ; Ganesan P; Janku F; Karp DD; Subbiah V; Mihm MC; Ross JS
Cancer; 2016 Jan; 122(2):249-57. PubMed ID: 26479420
[TBL] [Abstract][Full Text] [Related]
12. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
Li F; Liao J; Duan X; He Y; Liao Y
J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced cutaneous squamous cell carcinomas with epidermal growth factor receptor inhibitors.
Alter M; Satzger I; Mattern A; Kapp A; Gutzmer R
Dermatology; 2013; 227(4):289-94. PubMed ID: 24217470
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous squamous cell carcinoma: state of the art, perspectives and unmet needs.
Heppt MV; Leiter U
J Dtsch Dermatol Ges; 2023 Apr; 21(4):421-424. PubMed ID: 36999577
[TBL] [Abstract][Full Text] [Related]
16. New and emerging drugs for the treatment of advanced cutaneous squamous cell carcinoma.
Bonini F; de Sousa LG; Ferrarotto R
Expert Opin Emerg Drugs; 2023 Dec; 28(2):97-106. PubMed ID: 37144289
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Squamous Cell Carcinoma: From Biology to Therapy.
Corchado-Cobos R; García-Sancha N; González-Sarmiento R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331425
[TBL] [Abstract][Full Text] [Related]
18. Molecular Approach to Cutaneous Squamous Cell Carcinoma: From Pathways to Therapy.
Palazzo E; Morasso MI; Pincelli C
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059344
[TBL] [Abstract][Full Text] [Related]
19. Comparison of guidelines for the management of patients with high-risk and advanced cutaneous squamous cell carcinoma - a systematic review.
Heppt MV; Steeb T; Berking C; Nast A
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():25-32. PubMed ID: 31833609
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of advanced cutaneous squamous-cell carcinoma.
Gellrich FF; Hüning S; Beissert S; Eigentler T; Stockfleth E; Gutzmer R; Meier F
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():38-43. PubMed ID: 31833610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]